Ocean Biomedical Reports Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report On Form 10-Q

0.00%

OCEAN BIOMEDICAL, INC.

OCEA

Ocean Biomedical has determined to restate its consolidated financial statements as of and for the quarters ended March 31, 2023 and June 30, 2023. Nasdaq indicated that the company must, no later than January 22, 2024, submit a plan to regain compliance with respect to the filing requirement.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.